Can Ranbaxy recover from its US debacle?

"We are pleased to have resolved this legacy issue with the FDA as we begin the next chapter in Ranbaxy's history," stated Arun Sawhney, CEO & Managing Director of India's biggest drug-maker......

Ranbaxy introduces whistle-blower policy

Trouble-hit Ranbaxy Laboratories has introduced a whistle-blower policy within the company to encourage transparency and address concerns internally, so that bigger problems could be averted.In his......

I can stand behind every pill: Ranbaxy CEO

Drug maker Ranbaxy Laboratories, which recently pleaded guilty of making fraudulent statements to the US Food and Drugs Administration and agreed to pay $500 million as penalty, now believes the......

Ranbaxy returns to profit in Q2 on robust volumes

Drug firm Ranbaxy Laboratories on Monday reported a consolidated net profit of Rs 477.75 crore (Rs 4.77 billion)for the quarter ended September 30, 2014 on account of robust sales. The company had......